QURE Q1 2026 Earnings NarrowerthanExpected Loss as Gene Therapy Developer Continues Pipeline Progress YPF Q4 2025 Earnings Massive Reported Loss Despite Positive Stock Movement GPGI Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines BancFirst Corporation BANF Q1 2026 Earnings Solid EPS Beat Amid Steady Operating Performance Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress SNAL Q1 2026 Earnings EPS Surges Past Estimates Amid Tight Cost Controls